Journal Article

O’Donnell-Luria-Rodan syndrome: description of a second multinational cohort and refinement of the phenotypic spectrum

Rodan, Lance H, Schaaf, Christian P, Denommé-Pichon, Anne-Sophie, Lessmeier, Lennart, Coubes, Christine, Aubert Mucca, Marion, Gerard, Marion, Chan, Marcus CY, Clark, Robin, Ramanathan, Subhadra, Netzer, Christian, Sherr, Elliott, Argilli, Emanuela, Kennedy, Colleen, Aarts-Tesselaar, Coranne, Fung, Jasmine Lee-Fong, Paterson, Heather, Kumps, Camille, England, Eleina, Funalot, Benoit, Pais, Lynn S, van de Laar, Ingrid M B.H, Lehalle, Daphné, Willems, Marjolaine, O'Donnell-Luria, Anne H, Chung, Brian H.Y., Velmans, Clara, Vitobello, Antonio, Carmichael, Jason, de Dios, John Karl, Leppig, Kathleen, Erger, Florian, Superti-Furga, Andrea, Joseph, Maries, Rech, Megan, van Slegtenhorst, Marjon, Abicht, Angela, Chassaing, Nicolas, Tran Mau-them, Frederic

2022

Overview

BackgroundO’Donnell-Luria-Rodan syndrome (ODLURO) is an autosomal-dominant neurodevelopmental disorder caused by pathogenic, mostly truncating variants in KMT2E. It was first described by O’Donnell-Luria et al in 2019 in a cohort of 38 patients. Clinical features encompass macrocephaly, mild intellectual disability (ID), autism spectrum disorder (ASD) susceptibility and seizure susceptibility.MethodsAffected individuals were ascertained at paediatric and genetic centres in various countries by diagnostic chromosome microarray or exome/genome sequencing. Patients were collected into a case cohort and were systematically phenotyped where possible.ResultsWe report 18 additional patients from 17 families with genetically confirmed ODLURO. We identified 15 different heterozygous likely pathogenic or pathogenic sequence variants (14 novel) and two partial microdeletions of KMT2E. We confirm and refine the phenotypic spectrum of the KMT2E-related neurodevelopmental disorder, especially concerning cognitive development, with rather mild ID and macrocephaly with subtle facial features in most patients. We observe a high prevalence of ASD in our cohort (41%), while seizures are present in only two patients. We extend the phenotypic spectrum by sleep disturbances.ConclusionOur study, bringing the total of known patients with ODLURO to more than 60 within 2 years of the first publication, suggests an unexpectedly high relative frequency of this syndrome worldwide. It seems likely that ODLURO, although just recently described, is among the more common single-gene aetiologies of neurodevelopmental delay and ASD. We present the second systematic case series of patients with ODLURO, further refining the mutational and phenotypic spectrum of this not-so-rare syndrome.

• Publisher: BMJ Publishing Group Ltd,BMJ Publishing Group LTD,BMJ Publishing Group
• Subject: Autism / Autism Spectrum Disorder - genetics / behavioural / Cell cycle / Child / Chromosomes / Cognitive ability / Cognitive and behavioural genetics / Convulsions & seizures / DNA microarrays / Exome Sequencing / Fathers / Genes / genetic counselling / Genetics / Genomes / Genomics / Genotype & phenotype / Hereditary diseases / Human genetics / Humans / Intellectual disabilities / Intellectual Disability - diagnosis / Intellectual Disability - epidemiology / Intellectual Disability - genetics / Life Sciences / Macrocephaly / Megalencephaly / Microcephaly / mutation / Neurodevelopmental Disorders / Patients / Seizures / Seizures - epidemiology / Seizures - genetics / Syndrome / Whole genome sequencing